Evidence map›Paper›PMID 41775791›Full record

ArticleNPJ digital medicine2026

A domain-adaptive deep contrastive network for magnetic resonance imaging-driven bladder cancer classification.

Junjun Huang, Haixia Hu, Mengdan Sun, Weiting Wu, Keyi Xu, Juan Xu, Xufeng Sun, Dongdong Hu, Dandan Yao, Tianran He and 3 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. A risk-adapted approach to reTURBT in high-grade T1 NMIBC.Bladder cancer (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Junjun HuangDepartment of Artificial Intelligence, Faculty of Computer Science and Information Technology, Universiti Malaya, Kuala Lumpur, Malaysia.
Haixia HuCixi Third People's Hospital Medical Health Group (Cixi Third People's Hospital), Cixi, Zhejiang, China.
Mengdan SunCixi City Hushan Subdistrict Community Health Service Center, Ningbo, Zhejiang Province, China.
Weiting WuNingbo Xinwell Medical Technology Co. Ltd., Zhejiang, China.
Keyi XuNingbo Xinwell Medical Technology Co. Ltd., Zhejiang, China.
Juan XuNingbo Xinwell Medical Technology Co. Ltd., Zhejiang, China.
Xufeng SunNingbo Xinwell Medical Technology Co. Ltd., Zhejiang, China.
Dongdong HuNingbo Xinwell Medical Technology Co. Ltd., Zhejiang, China.
Dandan YaoNingbo Xinwell Medical Technology Co. Ltd., Zhejiang, China.
Tianran HeSchool of Electronic and Information Engineering, Tongji University, Shanghai, China.
Wei WeiSchool of Computer Science and Engineering, Xi'an University of Technology, Xi'an, China.
Baiyang SongDepartment of Urology, The First Affiliated Hospital of Ningbo University, Ningbo, China. scholar.pakyoung@gmail.com.
Li FangDepartment of Urology, The First Affiliated Hospital of Ningbo University, Ningbo, China. fyyfangli@nbu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer is one of the most prevalent malignancies of the urinary system and is associated with high morbidity and mortality. With advances in medical image analysis, deep learning has shown promise for automated bladder cancer classification using magnetic resonance imaging (MRI). However, clinical deployment remains challenging due to substantial inter-center distributional discrepancies and limited feature discriminability between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC). To address these challenges, we propose a Domain-Adaptive Deep Contrastive Network (DADCNet) for MRI-based bladder cancer classification. The proposed framework jointly incorporates source- and target-domain samples during feature learning to obtain domain-invariant yet discriminative representations, thereby improving cross-center generalization. In addition, a deep contrastive learning strategy is introduced to enhance inter-class separability and intra-class compactness, leading to more robust classification. Experiments conducted on a multi-center bladder cancer MRI dataset demonstrate that DADCNet consistently outperforms existing convolutional neural network- and Transformer-based methods, achieving an accuracy of 0.955, an F1-score of 0.955, and an area under the curve of 0.991.

Identifiers

PMID41775791
PMCPMC13066578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.